Activity of targeted therapy after failure of first-line immunotherapy in BRAF-mutant metastatic melanoma

Cathy Yi Xia; Daniel Ying Wang; Robert Mason; Jessica Louise Smith; Meredith Ann McKean; Serigne Lo; Alexander David Guminski; Georgina V. Long; Matteo S. Carlino; Victoria Atkinson; Michael Millward; Jennifer Leigh McQuade; Rodabe Navroze Amaria; Douglas Buckner Johnson; Alexander M. Menzies

doi:10.1200/JCO.2018.36.15_suppl.9532

Activity of targeted therapy after failure of first-line immunotherapy in BRAF-mutant metastatic melanoma

Cathy Yi Xia, Daniel Ying Wang, Robert Mason, Jessica Louise Smith, Meredith Ann McKean, Serigne Lo, Alexander David Guminski, Georgina V. Long, Matteo S. Carlino, Victoria Atkinson, Michael Millward, Jennifer Leigh McQuade, Rodabe Navroze Amaria, Douglas Buckner Johnson, Alexander M. Menzies

Internal Medicine

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

8 Citations (Web of Science)

Original language	English
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	36
Issue number	15
DOIs	https://doi.org/10.1200/JCO.2018.36.15_suppl.9532
Publication status	Published - 20 May 2018

Access to Document

10.1200/JCO.2018.36.15_suppl.9532

Cite this

Xia, C. Y., Wang, D. Y., Mason, R., Smith, J. L., McKean, M. A., Lo, S., Guminski, A. D., Long, G. V., Carlino, M. S., Atkinson, V., Millward, M., McQuade, J. L., Amaria, R. N., Johnson, D. B., & Menzies, A. M. (2018). Activity of targeted therapy after failure of first-line immunotherapy in BRAF-mutant metastatic melanoma. Journal of Clinical Oncology, 36(15). https://doi.org/10.1200/JCO.2018.36.15_suppl.9532

@article{d4674bacfaf94d6f875393c7e6fe297c,

title = "Activity of targeted therapy after failure of first-line immunotherapy in BRAF-mutant metastatic melanoma",

author = "Xia, {Cathy Yi} and Wang, {Daniel Ying} and Robert Mason and Smith, {Jessica Louise} and McKean, {Meredith Ann} and Serigne Lo and Guminski, {Alexander David} and Long, {Georgina V.} and Carlino, {Matteo S.} and Victoria Atkinson and Michael Millward and McQuade, {Jennifer Leigh} and Amaria, {Rodabe Navroze} and Johnson, {Douglas Buckner} and Menzies, {Alexander M.}",

year = "2018",

month = may,

day = "20",

doi = "10.1200/JCO.2018.36.15_suppl.9532",

language = "English",

volume = "36",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15",

}

Xia, CY, Wang, DY, Mason, R, Smith, JL, McKean, MA, Lo, S, Guminski, AD, Long, GV, Carlino, MS, Atkinson, V, Millward, M, McQuade, JL, Amaria, RN, Johnson, DB & Menzies, AM 2018, 'Activity of targeted therapy after failure of first-line immunotherapy in BRAF-mutant metastatic melanoma', Journal of Clinical Oncology, vol. 36, no. 15. https://doi.org/10.1200/JCO.2018.36.15_suppl.9532

TY - JOUR

T1 - Activity of targeted therapy after failure of first-line immunotherapy in BRAF-mutant metastatic melanoma

AU - Xia, Cathy Yi

AU - Wang, Daniel Ying

AU - Mason, Robert

AU - Smith, Jessica Louise

AU - McKean, Meredith Ann

AU - Lo, Serigne

AU - Guminski, Alexander David

AU - Long, Georgina V.

AU - Carlino, Matteo S.

AU - Atkinson, Victoria

AU - Millward, Michael

AU - McQuade, Jennifer Leigh

AU - Amaria, Rodabe Navroze

AU - Johnson, Douglas Buckner

AU - Menzies, Alexander M.

PY - 2018/5/20

Y1 - 2018/5/20

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uwapure5-25&SrcAuth=WosAPI&KeyUT=WOS:000442916003308&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1200/JCO.2018.36.15_suppl.9532

DO - 10.1200/JCO.2018.36.15_suppl.9532

M3 - Abstract/Meeting Abstract

SN - 0732-183X

VL - 36

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

ER -

Activity of targeted therapy after failure of first-line immunotherapy in BRAF-mutant metastatic melanoma

Access to Document

Other files and links

Cite this